Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial

DSpace Repository

Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial

Author: Shiffman, Mitchell L.; Cheinquer, Hugo; Berg, Christoph P.; Berg, Thomas; de Figueiredo-Mendes, Claudio; Dore, Gregory J.; Ferraz, Maria Lucia; Mendes-Correa, Maria Cassia; Lima, Maria Patelli; Parise, Edison R.; Perez Rios, Alma Minerva; Reuter, Tania; Sanyal, Arun J.; Shafran, Stephen D.; Hohmann, Marc; Tatsch, Fernando; Bakalos, George; Zeuzem, Stefan
Tübinger Autor(en):
Berg, Christoph Peter
Published in: Hepatology International (2014), Bd. 8, H. 4, S. 517-526
Verlagsangabe: Springer
Language: English
Full text: http://dx.doi.org/10.1007/s12072-014-9555-3
ISSN: 1936-0533
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)